Glucose intolerance and diabetes following antigen-specific insulitis in diabetes-susceptible "humanized" transgenic mice

Biochemical and Biophysical Research Communications

Volumn 395, Issue 1, 2010, Pages 99-103

  Elagin, Raya B ^a   Jaume, Juan C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Autoimmune diabetes; GAD; GAD65; MHC class II; Mouse model; Type 1

Indexed keywords

ADENOVIRUS VECTOR; AUTOANTIGEN; COMPLEMENTARY DNA; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; HLA DQ8 ANTIGEN; INSULIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; HLA DQ ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNITY; CELL LOSS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DISEASE PREDISPOSITION; DNA IMMUNIZATION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HAPLOTYPE; HUMORAL IMMUNITY; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLUCOSE INTOLERANCE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; IMMUNITY, HUMORAL; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 77951935785     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.146     Document Type: Article

References (20)

1. J.A. Todd, J.I. Bell, H.O. McDevitt, HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus, Nature 329 (1997) 599-604.
2. S. Baekkeskov, J. Kanaani, J.C. Jaume, S. Kash, Does GAD have a unique role in triggering IDDM?, J Autoimmun. 15 (2000) 279-286.
3. M.R. Christie, G. Vohra, P. Champagne, D. Daneman, T.L. Delovitch, Distinct antibody specificities to a 64-kDa islet cell antigen in type 1 diabetes as revealed by trypsin treatment, J. Exp. Med. 172 (1990) 789-794.
4. D.U. Rabin, S.M. Pleasic, J.A. Shapiro, H. Yoo-Warren, J. Oles, J.M. Hicks, D.E. Goldstein, P.M. Rae, Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases, J. Immunol. 152 (1994) 3183-3188.
5. W.A. Hagopian, B. Michelsen, A.E. Karlsen, F. Larsen, A. Moody, C.E. Grubin, R. Rowe, J. Petersen, R. McEvoy, A. Lernmark, Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase, Diabetes 42 (1993) 631-636.
6. J. Kim, W. Richter, H.J. Aanstoot, Y. Shi, Q. Fu, R. Rajotte, G. Warnock, S. Baekkeskov, Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets, Diabetes 42 (1993) 1799-1808.
7. J.C. Jaume, Endocrine autoimmunity, in: D.G. Gardner, D.M. Shoback (Eds.), Greenspan's Basic & Clinical Endocrinology, eighth ed., McGraw-Hill Medical, New York, 2007, pp. 59-79.
8. R.B. Elagin, S. Balijepalli, M.J. Diacovo, S. Baekkeskov, J.C. Jaume, Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice, J. Autoimmun. 33 (2009) 50-57.
9. J.P. Stoehr, S.T. Nadler, K.L. Schueler, M.E. Rabaglia, B.S. Yandell, S.A. Metz, A.D. Attie, Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci, Diabetes 49 (2000) 1946-1954.
10. M.P. Keller, Y. Choi, P. Wang, D.B. Davis, M.E. Rabaglia, A.T. Oler, D.S. Stapleton, C. Argmann, K.L. Schueler, S. Edwards, H.A. Steinberg, E. Chaibub Neto, R. Kleinhanz, S. Turner, M.K. Hellerstein, E.E. Schadt, B.S. Yandell, C. Kendziorski, A.D. Attie, A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility, Genome Res. 18 (2008) 706-716.
11. + T cells from human DQ transgenic mice, J. Clin. Invest. 102 (1998) 947-957.
12. Y. Shi, J. Kanaani, V. Menard-Rose, Y.H. Ma, P.Y. Chang, D. Hanahan, A. Tobin, G. Grodsky, S. Baekkeskov, Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion, Am. J. Physiol. Endocrinol. Metab. 279 (2000) 684-694.
13. M.G. Kaplitt, A. Feigin, C. Tang, H.L. Fitzsimons, P. Mattis, P.A. Lawlor, R.J. Bland, D. Young, K. Strybing, D. Eidelberg, M.J. During, Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial, Lancet 369 (2007) 2097-2105.
14. Z.C. Hartman, D.M. Appledorn, A. Amalfitano, Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications, Virus Res. 132 (2008) 1-14.
15. L.C. Dunn, A fifth allelomorph in the agouti series of the house mouse, Proc. Natl. Acad. Sci. USA 14 (1928) 816-819.
16. S.J. Bultman, E.J. Michaud, R.P. Woychik, Molecular characterization of the mouse agouti locus, Cell 71 (1992) 1195-1204.
17. M. Mehrabian, P.-Z. Wen, J. Fisher, R.C. Davis, A.J. Lusis, Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model, J. Clin. Invest. 101 (1998) 2485-2496.
18. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors, Diabetes 42 (1993) 44-55.
19. D.L. Eizirik, M.L. Colli, F. Ortis, The role of inflammation in insulitis and beta-cell loss in type 1 diabetes, Nat. Rev. Endocrinol. 5 (2009) 219-226.
20. J. Ludvigsson, M. Faresjö, M. Hjorth, S. Axelsson, M. Chéramy, M. Pihl, O. Vaarala, G. Forsander, S. Ivarsson, C. Johansson, A. Lindh, N.O. Nilsson, J. Aman, E. Ortqvist, P. Zerhouni, R. Casas, GAD treatment and insulin secretion in recent-onset type 1 diabetes, N. Engl. J. Med. 359 (2008) 1909-1920.